MENU
GLUE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Monte Rosa Therapeutics (GLUE) Ownership - Who owns Monte Rosa Therapeutics?
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins... Show more
Profile
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
304.47M
P/E Ratio
N/A
Total Cash
372.15M
Projected Growth
N/A
Total Debt
42.72M
Revenue
75.62M
Risk (Beta)
1.15
Dividend Yield
N/A
Total Cash/Share
6.05
Total Debt/Equity
N/A
Revenue/Share
1.02 USD as % of share price
Fundamentals
GLUE
Capitalization
304M
P/E Ratio
N/A
Risk (Beta)
1.15
Dividend Yield
N/A
Total Cash
372M
Total Cash/Share
6.05
Total Debt
42.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.02%
Revenue
75.6M
ROE
N/A
Book Value
223M
P/B Ratio
1.37
Cash Flow
N/A
Earnings
-0.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
2.40
Current Revenue Per Employee
452589.56
Dividends Per Share - Security
N/A
EBITDA
-72.99M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.58
Shares Held By Institutions
562M
Shares Outstanding - Current
61.5M
Total Liabilities
216M
Total Volume MTD
N/A
Value
1
Gain YTD
-28.674
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com